Research and publish the best content.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Already have an account: Login
Bioscience News - GEG Tech top picks
8.8K views |
+0 today
 Your new post is loading...
Your new post is loading...
Scoop.it!
Steroid Originally Discovered in the Dogfish Shark Attacks Parkinson’s-Related Toxin in Animal Model
BigField GEG Tech's insight:
A naturally occurring steroid made by the dogfish shark prevents the buildup of a lethal protein in animal studies, reports an international team of researchers. The clustering of this protein, alpha-synuclein (α-synuclein), is the hallmark of Parkinson’s disease and dementia with Lewy bodies, suggesting a new potential compound for therapeutic research. 
|
Scoop.it!
From
www
New research from UAB sheds light on the connection between Parkinson’s disease and the trillions of bacteria in our guts. There is growin
BigField GEG Tech's insight:
There is growing evidence showing a connection between Parkinson’s disease — a neurodegenerative condition — and the composition of the microbiome of the gut. A new study from researchers at the University of Alabama at Birmingham shows that Parkinson’s disease, and medications to treat Parkinson’s, have distinct effects on the composition of the trillions of bacteria that make up the gut microbiome.
Brian Chew's comment,
March 9, 2017 8:42 AM
This is a huge breakthrough for patients suffering from Parkinson's. This study that they just conducted would mean that new and better ways could be used to treat patients suffering from Parkinson's disease. Furthermore, it could also mean that ways to detect Parkinson's early or even ways to prevent Parkinson's in the future could be hopeful too
Scoop.it!
BigField GEG Tech's insight:
For the first time ever, viewers from across the world can tune in to National Geographic Channel to watch Brain Surgery Live, which is, as its name suggests, a live broadcast of brain surgery. In a procedure known as Deep Brain Stimulation (DBS), a team of neurosurgeons at UH Case Medical Center in Cleveland will attempt to reduce the symptoms of Parkinson’s disease that have manifested themselves in patient Greg Grindley, a 49-year-old electrician who will have the unique experience of having his brain shown to television audiences everywhere.
|
The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing “off” episodes. An “off” episode is a time when a patient’s medications are not working well, causing an increase in Parkinson’s symptoms, such as tremor and difficulty walking.